• KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Receives Average Recommendation of "Buy" from Analysts

    Источник: Buzz FX / 25 фев 2025 03:26:18   America/Chicago


    KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Receives Average Recommendation of "Buy" from Analysts Written by MarketBeat February 25, 2025 Share Link copied to clipboard. Shares of KalVista Pharmaceuticals, Inc.
    Read more...
Опубликовать